Home » Topics » BioWorld Science, Biomarkers

BioWorld Science, Biomarkers
RSS

HealthLinx initiates phase II biomarker trial of Ovplex test for ovarian cancer

Aug. 21, 2007

Renal impairment implicated in progression to prediabetes

July 17, 2007

diaDexus reports on Lp-PLA2's role in ischemic stroke risk evaluation

July 9, 2007

Dade Behring grants sublicense to Beckman Coulter on cardiac markers

June 29, 2007

Fujirebio receives new patent for HE4 biomarker with utility in ovarian cancer

June 11, 2007

TRPM8: novel prognostic marker and potential therapeutic target in prostate cancer

May 29, 2007

Na+/H+-exchange inhibitors reported by Hoechst

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...